HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Active immunotherapy of tumors with a recombinant xenogeneic endoglin as a model antigen.

Abstract
Angiogenesis play a critical role in tumor growth and metastasis. Increasing evidence suggests that endoglin is a powerful marker of angiogenesis in solid malignancies. Thus, breaking of immune tolerance of self-endoglin-associated angiogenesis is an attractive approach to cancer therapy. To test this concept, we recombined the extracellular domains of porcine endoglin, and used it as a xenogeneic vaccine. We found that immunotherapy with porcine endoglin was effective at both protective and therapeutic anti-tumor immunity in several mouse tumor models. Autoantibodies against mouse endoglin were identified by Western blot and ELISA. IgG1 and IgG2b were substantially increased. Anti-endoglin antibody-producing B cells were detectable by ELISPOT assay. There was endothelial deposition of immunoglobulins within tumors. The anti-tumor activity was also induced by the adoptive transfer of the purified immunoglobulins. Angiogenesis was apparently inhibited within the tumor tissues and on the alginate beads. The increased apoptotic cells were found within the tumor tissues from the mice treated with porcine endoglin. The anti-tumor activity and production of autoantibodies against mouse endoglin could be abrogated by depletion of CD4(+) T lymphocytes. Remarkably, no marked toxicity was found in the immunized mice. These observations may provide an alternative rational strategy for active cancer immunotherapy.
AuthorsGuang-Hong Tan, Yu-Quan Wei, Ling Tian, Xia Zhao, Li Yang, Jiong Li, Qiu-Ming He, Yang Wu, Yan-Jun Wen, Tao Yi, Zhen-Yu Ding, Bin Kan, Yong-Qiu Mao, Hong-Xin Deng, Hong-Li Li, Chun-Hua Zhou, Chun-Hua Fu, Fei Xiao, Xiao-Wei Zhang
JournalEuropean journal of immunology (Eur J Immunol) Vol. 34 Issue 7 Pg. 2012-21 (Jul 2004) ISSN: 0014-2980 [Print] Germany
PMID15214049 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD
  • Antigens, Heterophile
  • Autoantibodies
  • Biomarkers, Tumor
  • Cancer Vaccines
  • ENG protein, human
  • Endoglin
  • Receptors, Cell Surface
  • Recombinant Fusion Proteins
  • Vascular Cell Adhesion Molecule-1
Topics
  • Adoptive Transfer
  • Animals
  • Antigens, CD
  • Antigens, Heterophile (chemistry, immunology)
  • Apoptosis
  • Autoantibodies (immunology)
  • Biomarkers, Tumor (chemistry, immunology)
  • CD4-Positive T-Lymphocytes (immunology)
  • Cancer Vaccines (immunology)
  • Carcinoma, Lewis Lung (blood supply, immunology, pathology)
  • Endoglin
  • Immune Tolerance (immunology)
  • Melanoma, Experimental (immunology, pathology)
  • Mice
  • Mice, Inbred C57BL
  • Neoplasms (blood supply, immunology, pathology, therapy)
  • Neovascularization, Pathologic
  • Protein Structure, Tertiary
  • Receptors, Cell Surface
  • Recombinant Fusion Proteins (chemistry, immunology)
  • Swine (immunology)
  • Vaccination
  • Vascular Cell Adhesion Molecule-1 (chemistry, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: